BRIEF-Novartis CEO says takeover prices have risen, focusing on early-stage targets By: Reuters: Company News April 25, 2017 at 01:57 AM EDT * CEO Joe Jimenez says thinks with Cosentyx "we can hold our own" against lilly drug taltz Read More >> Related Stocks: Eli Lilly Novan Inc